Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry-Kravis

Showing results (191-200 of 265) with videos related to

Pageof 27
Sort By:
The Journal of Clinical Psychiatry|May 9, 2009
A review of fragile X premutation disorders: expanding the psychiatric perspectiveJames A Bourgeois, Sarah M Coffey, Susan M Rivera, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Longitudinal Trajectory of Adaptive Skills in Phelan-McDermid SyndromeSiddharth Srivastava, Kristina Johnson, Cristan Farmer, et al.
Journal of Genetic Counseling|May 15, 2007
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disordersAllyn McConkie-Rosell, Liane Abrams, Brenda Finucane, et al.
Journal of Neurodevelopmental Disorders|November 19, 2025
Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension studyElizabeth Berry-Kravis, Randi Hagerman, Jonathan Cohen, et al.
Journal of Neurodevelopmental Disorders|August 12, 2014
AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmissionCarolyn M Yrigollen, Loreto Martorell, Blythe Durbin-Johnson, et al.
Journal of Neurodevelopmental Disorders|August 7, 2014
Associated features in females with an FMR1 premutationAnne C Wheeler, Donald B Bailey, Elizabeth Berry-Kravis, et al.
Journal of Neurodevelopmental Disorders|April 30, 2025
Protein-truncating variants and deletions of SHANK2 are associated with autism spectrum disorder and other neurodevelopmental concernsHailey Silver, Rori Greenberg, Paige M Siper, et al.
Frontiers in Psychiatry|August 23, 2021
The Phenotypic Profile Associated With the <i>FMR1</i> Premutation in Women: An Investigation of Clinical-Behavioral, Social-Cognitive, and Executive AbilitiesNell Maltman, Janna Guilfoyle, Kritika Nayar, et al.
Pediatric Neurology|November 7, 2018
Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSiddharth Srivastava, Benoit Scherrer, Anna K Prohl, et al.
Nature Communications|November 12, 2024
A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseasesOlivia Kim-McManus, Joseph G Gleeson, Laurence Mignon, et al.
Pageof 27

Showing results (191-200 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Clinical Psychiatry|May 9, 2009
A review of fragile X premutation disorders: expanding the psychiatric perspectiveJames A Bourgeois, Sarah M Coffey, Susan M Rivera, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Longitudinal Trajectory of Adaptive Skills in Phelan-McDermid SyndromeSiddharth Srivastava, Kristina Johnson, Cristan Farmer, et al.
Journal of Genetic Counseling|May 15, 2007
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disordersAllyn McConkie-Rosell, Liane Abrams, Brenda Finucane, et al.
Journal of Neurodevelopmental Disorders|November 19, 2025
Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension studyElizabeth Berry-Kravis, Randi Hagerman, Jonathan Cohen, et al.
Journal of Neurodevelopmental Disorders|August 12, 2014
AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmissionCarolyn M Yrigollen, Loreto Martorell, Blythe Durbin-Johnson, et al.
Journal of Neurodevelopmental Disorders|August 7, 2014
Associated features in females with an FMR1 premutationAnne C Wheeler, Donald B Bailey, Elizabeth Berry-Kravis, et al.
Journal of Neurodevelopmental Disorders|April 30, 2025
Protein-truncating variants and deletions of SHANK2 are associated with autism spectrum disorder and other neurodevelopmental concernsHailey Silver, Rori Greenberg, Paige M Siper, et al.
Frontiers in Psychiatry|August 23, 2021
The Phenotypic Profile Associated With the <i>FMR1</i> Premutation in Women: An Investigation of Clinical-Behavioral, Social-Cognitive, and Executive AbilitiesNell Maltman, Janna Guilfoyle, Kritika Nayar, et al.
Pediatric Neurology|November 7, 2018
Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSiddharth Srivastava, Benoit Scherrer, Anna K Prohl, et al.
Nature Communications|November 12, 2024
A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseasesOlivia Kim-McManus, Joseph G Gleeson, Laurence Mignon, et al.
Pageof 27